Not logged in.png)
Share.png)
SaveShare Save Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
Chang, Eileen L.; Liu, Renee; Keyhanian, Kiandokht; Huynh, Katie; Berkenstock, Meghan; Bhatti, M. Tariq; Chen, John J.; Chodosh, James; Costello, Fiona; Dalvin, Lauren A.; Delott, Lindsey B.; Dinkin, Marc; Egan, Robert A.; Fraser, Clare L.; Freitag, Suzanne K.; Gangaputra, Sapna; Gordon, Lynn K.; Guidon, Amanda C.; Johnson, Douglas B.; Kombo, Ninani; Kramer, Michal; Lee, Andrew G.; Levy, Michael; Lobo-Chan, Anne-Marie; Mantopoulos, Dimosthenis; Papaliodis, George; Pless, Misha; Pimkina, Julia; Rubin, Krista M.; Sen, H. Nida; Shariff, Afreen; Subramanian, Prem S.; Tsui, Edmund; Yoon, Michael K.; Mcdunn, Jon; Rine, Johnathan; Reynolds, Kerry L.; Sobrin, Lucia; Chwalisz, Bart K. Share Save Share Save Share Save Share Save A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL TrialClarke, Jeffrey M.; Gu, Lin; Wang, Xiaofei F.; Stinchcombe, Thomas E.; Stevenson, Marvaretta M.; Ramalingam, Sundhar; Shariff, Afreen; Garst, Jennifer; Nixon, Andrew B.; Antonia, Scott J.; Crawford, Jeffrey; Ready, Neal E. Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
